# Analysis and validation of necroptosis-related diagnostic biomarkers associated with immune infiltration in bronchopulmonary dysplasia

**Authors:** Haixia Tu, Changjiang Fang, Ping Gan, Yunyun Gu, Nana Peng, Honghua Jiang, Weiwei Hou, Guihua Shu

PMC · DOI: 10.3389/fped.2025.1578628 · 2025-07-15

## TL;DR

This study identifies a necroptosis-related gene, STAT4, as a potential diagnostic marker for bronchopulmonary dysplasia and explores its link to immune infiltration.

## Contribution

The study introduces a diagnostic nomogram based on necroptosis-related genes and evaluates their relationship with immune infiltration in BPD.

## Key findings

- 27 differentially expressed necroptosis-related genes were identified, including those involved in necroptosis and inflammatory response.
- Three hub genes (PELI1, PYGL, and STAT4) were selected, with STAT4 showing diagnostic potential (AUC > 0.7).
- Immune infiltration analysis revealed differences in six immune cell types between BPD and control groups.

## Abstract

Bronchopulmonary dysplasia (BPD) is the most common serious complication in very preterm infants. This study aims to identify necroptosis-related genes (NRGs) and analyze the relationship between necroptosis-related diagnostic markers and immune infiltration in BPD.

We obtained the dataset GSE32472 from the GEO database and analyzed the differentially expressed NRGs (DE-NRGs). We identified the biological functions and pathways of DE-NRGs. RF (random forest) and LASSO (least absolute shrinkage and selection operator) algorithms were applied to identify hub genes. We explored the immune landscape of BPD and controls by CIBERSORT. The correlations between hub genes and immune cells were evaluated using Spearman correlation analysis. ELISA was used to verify the diagnostic value of hub genes in patients with BPD in our hospital.

27 DE-NRGs were screened. We found the primary biological functions and pathways of DE-NRGs, including necroptosis, and regulation of inflammatory response. Three hub genes (PELI1, PYGL, and STAT4) were identified and utilized to construct a diagnostic nomogram. The AUC value of the nomogram was greater than 0.7 in the validation dataset GSE188944. CIBERSORT showed that the proportions of 6 different immune cell types in the BPD group were higher or lower than the control group (P < 0.05). Correlation analysis showed that three hub genes may correlate with immune cells to varying degrees. Serum ELISA results of PELI1 and PYGL showed no significant difference between BPD and Controls (P > 0.05), the expression level of STAT4 was downregulated in BPD samples (P < 0.05), and the AUC value of the STAT4 was higher than 0.7.

The necroptosis-related gene STAT4 can be a diagnostic marker of BPD patients. The necroptosis-related gene and immune infiltration may be related to the progression of BPD.

## Linked entities

- **Genes:** PELI1 (pellino E3 ubiquitin protein ligase 1) [NCBI Gene 57162], PYGL (glycogen phosphorylase L) [NCBI Gene 5836], STAT4 (signal transducer and activator of transcription 4) [NCBI Gene 6775]
- **Diseases:** bronchopulmonary dysplasia (MONDO:0019091)

## Full-text entities

- **Genes:** MEFV (MEFV innate immunity regulator, pyrin) [NCBI Gene 4210] {aka FMF, MEF, PAAND, TRIM20}, MLKL (mixed lineage kinase domain like pseudokinase) [NCBI Gene 197259] {aka hMLKL}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, PARP1 (poly(ADP-ribose) polymerase 1) [NCBI Gene 142] {aka ADPRT, ADPRT 1, ADPRT1, ARTD1, PARP, PARP-1}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CFLAR (CASP8 and FADD like apoptosis regulator) [NCBI Gene 8837] {aka CASH, CASP8AP1, CLARP, Casper, FLAME, FLAME-1}, EIF2AK2 (eukaryotic translation initiation factor 2 alpha kinase 2) [NCBI Gene 5610] {aka PKR, PPP1R83, PRKR}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, RIPK3 (receptor interacting serine/threonine kinase 3) [NCBI Gene 11035] {aka RIP3}, STAT4 (signal transducer and activator of transcription 4) [NCBI Gene 6775] {aka DPMC, SLEB11}, Peli1 (pellino 1) [NCBI Gene 67245] {aka 2810468L03Rik, A930031K15Rik, D11Ertd676e}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, FTH1 (ferritin heavy chain 1) [NCBI Gene 2495] {aka FHC, FTH, FTHL6, HFE5, NBIA9, PIG15}, BIRC3 (baculoviral IAP repeat containing 3) [NCBI Gene 330] {aka AIP1, API2, CIAP2, HAIP1, HIAP1, IAP-1}, IFNGR2 (interferon gamma receptor 2) [NCBI Gene 3460] {aka AF-1, IFGR2, IFNGT1, IMD28}, MYC (MYC proto-oncogene, bHLH transcription factor) [NCBI Gene 4609] {aka MRTL, MYCC, bHLHe39, c-Myc}, CAPN2 (calpain 2) [NCBI Gene 824] {aka CANP2, CANPL2, CANPml, mCANP}, Tceal1 (transcription elongation factor A (SII)-like 1) [NCBI Gene 237052] {aka 0610011M09Rik, P21, SIIR, pp21}, TRAF5 (TNF receptor associated factor 5) [NCBI Gene 7188] {aka MGC:39780, RNF84}, PYGL (glycogen phosphorylase L) [NCBI Gene 5836] {aka GSD6}, PELI1 (pellino E3 ubiquitin protein ligase 1) [NCBI Gene 57162], MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, CAMK2D (calcium/calmodulin dependent protein kinase II delta) [NCBI Gene 817] {aka CAMKD}, Pygl (liver glycogen phosphorylase) [NCBI Gene 110095], Stat4 (signal transducer and activator of transcription 4) [NCBI Gene 20849], FASLG (Fas ligand) [NCBI Gene 356] {aka ALPS1B, APT1LG1, APTL, CD178, CD95-L, CD95L}, RIPK1 (receptor interacting serine/threonine kinase 1) [NCBI Gene 8737] {aka AIEFL, IMD57, RIP, RIP-1, RIP1}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}
- **Diseases:** respiratory disease (MESH:D012140), BPD (MESH:D001997), respiratory disorders (MESH:D012131), DE (MESH:D003635), lung damage (MESH:D008171), chronic lung illness (MESH:D055370), tuberculosis (MESH:D014376), emphysema (MESH:D004646), lung adenocarcinoma (MESH:D000077192), lung cancer (MESH:D008175), chronic pulmonary disease (MESH:D002908), atherosclerosis (MESH:D050197), PAH (MESH:D000081029), necrosis (MESH:D009336), lung infections (MESH:D012141), pulmonary hypertension (MESH:D006976), acute respiratory distress syndrome (MESH:D012128), COPD (MESH:D029424), intrauterine infection (MESH:D007239), cancer (MESH:D009369), NRGs (MESH:C535507), inflammatory (MESH:D007249), ALI (MESH:D055371)
- **Chemicals:** lipid (MESH:D008055), D-galactose (MESH:D005690)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Figures

10 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12303952/full.md

---
Source: https://tomesphere.com/paper/PMC12303952